Women's Health Therapeutics
A Global Strategic Business Report
MCP23094
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (14630)
314
CXO889
VICE PRESIDENT6126
DIRECTOR5507
MANAGER1794
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Women's Health Therapeutics Market to Reach US$45.4 Billion by 2030
The global market for Women's Health Therapeutics estimated at US$22.0 Billion in the year 2024, is expected to reach US$45.4 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Postmenopausal Osteoporosis, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$18.1 Billion by the end of the analysis period. Growth in the Hormonal Infertility segment is estimated at 10.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$5.6 Billion While China is Forecast to Grow at 17.2% CAGR
The Women's Health Therapeutics market in the U.S. is estimated at US$5.6 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 17.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.4% and 10.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.
Global Women`s Health Therapeutics Market - Key Drivers and Trends Summarized
Women`s health therapeutics encompass a broad range of medical treatments and solutions specifically designed to address health issues that affect women. This category includes medications, therapies, and preventive treatments targeting conditions unique to or more prevalent in women, such as breast cancer, cervical cancer, osteoporosis, menopause, and reproductive health disorders. These therapeutics aim to improve the quality of life and health outcomes for women across various life stages, supporting both physical and reproductive health. With an increasing demand for health services that cater to women through various stages of life—from puberty to post-menopause—the landscape of women`s health therapeutics is expanding.
The market for women`s health therapeutics is driven by several key factors, notably the increasing awareness and advocacy around women`s health issues. Public health campaigns and women`s advocacy groups have been pivotal in increasing awareness about diseases such as breast and ovarian cancer, leading to earlier diagnosis and treatment. The aging female population globally is another significant driver, as older women are more likely to experience chronic health issues such as cardiovascular diseases, osteoporosis, and menopausal health concerns. Furthermore, advancements in pharmaceuticals and biotechnology have led to the development of more effective treatments for conditions specific to women, enhancing patient outcomes and extending life expectancies. These advancements include hormone replacement therapies, targeted cancer therapies, and improved fertility treatments, which have all seen significant innovation and adoption in recent years.
Recent trends in the women`s health therapeutics market indicate a shift towards personalized medicine and targeted therapies. There is a growing focus on developing treatments tailored to the genetic and molecular profiles of individual patients, particularly in areas such as breast and ovarian cancer, where biomarkers and genetic tests can predict treatment responses. Additionally, there is an increasing investment in research and development of non-hormonal therapies for managing menopause symptoms, driven by the demand for alternatives to traditional hormone replacement therapies, which can have significant side effects. Another notable trend is the integration of digital health technologies, including mobile health apps and wearable devices, designed to support women`s health management by tracking vital health metrics and providing personalized health insights. These technologies are playing a crucial role in empowering women to take charge of their health, offering tools for prevention, early detection, and management of various health conditions
SCOPE OF STUDY
The report analyzes the Women's Health Therapeutics market by the following Segments, and Geographic Regions/Countries:
Segments:
Application (Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause, Other Applications).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
AstraZeneca; Bayer AG; Bristol-Myers Squibb Company; CooperSurgical, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; GlaxoSmithKline plc; Merck & Co., Inc.; Mylan N.V.; Novartis AG
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Global Economic Update |
| Women's Health Therapeutics – Global Key Competitors Percentage Market Share in 2024 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 36 Players Worldwide in 2024 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Increasing Prevalence of Chronic Diseases in Women |
| Growing Awareness and Focus on Women's Health Issues |
| Advancements in Hormonal Therapies |
| Expansion of Personalized Medicine in Women's Health |
| Rising Demand for Non-Invasive Therapeutic Solutions |
| Adoption of Digital Health Technologies and Telemedicine |
| Increasing Investment in Women's Health Startups |
| Impact of Aging Population on Therapeutics Demand |
| Development of Novel Drug Delivery Systems |
| Expansion of Preventive Healthcare Services |
| Influence of Lifestyle Changes and Urbanization |
| Rising Demand for Fertility and Reproductive Health Solutions |
| Growing Importance of Mental Health and Wellness for Women |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Women's Health Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Postmenopausal Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Postmenopausal Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Postmenopausal Osteoporosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hormonal Infertility by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hormonal Infertility by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hormonal Infertility by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Polycystic Ovary Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Polycystic Ovary Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Polycystic Ovary Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Endometriosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Endometriosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Endometriosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Women's Health Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| JAPAN |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| CHINA |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| EUROPE |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Women's Health Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| FRANCE |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| GERMANY |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Women's Health Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| INDIA |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Women's Health Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Women's Health Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
| AFRICA |
| Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]